USFDA-approved parenteral peptide formulations and excipients: Industrial perspective
Authors:
- Samarth KumarSKSamarth Kumar
- Sachin N. SanapSSSachin N. Sanap
- Milan VasoyaMVMilan Vasoya
- Mayank HandaMHMayank Handa
- Prachi PandeyPPPrachi Pandey
- Ajay KhopadeAKAjay Khopade
- Krutika K. SawantKSKrutika K. Sawant
- 15 March 2024
- journal article
- review article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 95
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Strategic Approaches to Improvise Peptide Drugs as Next Generation TherapeuticsInternational Journal of Peptide Research and Therapeutics, 2023
- Peptide Aggregation Induced Immunogenic Rupture (PAIIR)Advanced Science, 2022
- Armamentarium of Cryoprotectants in Peptide Vaccines: Mechanistic Insight, Challenges, Opportunities and Future ProspectsInternational Journal of Peptide Research and Therapeutics, 2021
- Inhibition of protein misfolding and aggregation by natural phenolic compoundsCellular and Molecular Life Sciences, 2018
- Excipient Variability and Its Impact on Dosage Form FunctionalityJournal of Pharmaceutical Sciences, 2015
- Role of Benzyl Alcohol in the Unfolding and Aggregation of Interferon α-2aJournal of Pharmaceutical Sciences, 2015
- Methionine, tryptophan, and histidine oxidation in a model protein, PTH: Mechanisms and stabilizationJournal of Pharmaceutical Sciences, 2009
- In vitro hemolysis: Guidance for the pharmaceutical scientistJournal of Pharmaceutical Sciences, 2006
- Silicone Oil Induced Aggregation of ProteinsJournal of Pharmaceutical Sciences, 2005
- Excipient–Drug Interactions in Parenteral FormulationsJournal of Pharmaceutical Sciences, 2002